InsidersTradesSigma
Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
No hay puntuaciones de señal disponibles.
Browse the full record of transactions filed by Tiago Girao. Director active across 1 company, notably Immunovant, Inc.. Cumulatively, 1 reports have been published. Activity tracked since 26 June 2026. The latest transaction was filed on 26 June 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 de 1 declaracion